Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

Faster Test Results for Infection Lead to Safer and More Cost-Effective Hospitals The process of culture-based testing for microbes has been in common use for more than a century. In recent decades, ...

Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care Molecular Diagnostics Market Size & Growth Analysis: According to SNS Insider, The Point-of-Care Molecular Diagnostics Market ...

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...

5,000-participant, multi-center registry supported by iMDx’s central lab and transplant center partners New hospital-based data seeks to further differentiate pending kitted assay that measures ...

The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...

Join us for an insightful webinar on the critical role of molecular diagnostic testing for respiratory viruses during flu season. This session will explore the importance of accurate and timely ...

December 2024 was declared a "high severity" flu season by the Centre for Disease Control (CDC), the worst in over half a decade. Hospitalization rates were up to 2.8 times higher than the median ...

Q4 2025. Management View. CEO Joshua Riggs announced the submission of GraftAssureDx to the FDA, emphasizing, “ ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

The molecular diagnostics market size is expected to reach USD 38.01 billion by 2034, according to a new study by Polaris Market Research. The report “Molecular Diagnostics Market Size, Share, Trends, ...